Active Recombinant Human TNFRSF19, Fc Chimera

• Cat.No.: TNFRSF19-282H
• Product Overview: Recombinant Human TNFRSF19 (Accession # AAF71828) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Species: Human
• Source: Mammalian Cells
• Tag: Fc
• Predicted N Terminal: Glu30
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its binding ability in a functional ELISA.When Recombinant Human Lgr5/GPR49 Fc Chimera is coated at 0.5 µg/mL, Recombinant Human TROY/TNFRSF19 Fc Chimera binds with an apparent Kd <500 nM.
• Molecular Mass: Recombinant Human TNFRSF19, Fc Chimera has a calculated MW of 42 kDa (monomer). In SDS-PAGE migrates as 50-55 kDa, reducing conditions.
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: TNFRSF19 tumor necrosis factor receptor superfamily, member 19 [ Homo sapiens ]
• Official Symbol: TNFRSF19
• Synonyms: TNFRSF19; tumor necrosis factor receptor superfamily, member 19; tumor necrosis factor receptor superfamily member 19; TAJ; TAJ alpha; toxicity and JNK inducer; TRADE; TROY; TAJ-alpha
• Gene ID: 55504
• mRNA Refseq: NM_001204458
• Protein Refseq: NP_001191387
• MIM: 606122
• UniProt ID: Q9NS68
• Chromosome Location: 13q12.11-q12.3